Discovery of Fused Isoquinolinone/Triazole as a Scaffold for Tankyrase and PARP Inhibition
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.5c02481 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Konstantinos A Ouzounthanasis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Organic Chemistry, Department of Chemistry, Aristotle University, 54124 Thessaloniki, Greece. Hauptthemen laut MEDLINE: Tankyrases, Triazoles, Poly(ADP-ribose) Polymerase Inhibitors, Enzyme Inhibitors. Die Arbeit nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sigrid Jus?liuksen S??ti?, Hellenic Foundation for Research and Innovation, Research Council of Finland.
Abstract (Originalsprache)
A series of fused isoquinolinone/triazole hybrids were designed and prepared applying a unified versatile synthetic strategy. This practically involved three steps, a novel one-pot CuAAc "click" reaction-iodination process, an amidation and a copper-catalyzed intramolecular Ullmann cyclization and was found to be applicable for a variety of substitutions patterns on the main framework. Some of those synthesized hybrids were tested for selected ADP-ribosyltransferases and found to display nanomolar potency against TNKS2, whereas selectivity was also observed in comparison to other tested PARPs. The SAR studies divulged key structural features which are responsible for this selectivity. Moreover, the identification of the binding site of those selective derivatives using X-ray crystallography revealed that they are accommodated in the nicotinamide binding subsite while certain groups extend toward a hydrophobic pocket unique to tankyrases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Organic Chemistry, Department of Chemistry, Aristotle University, 54124 Thessaloniki, Greece.
- Faculty of Biochemistry and Molecular Medicine & Biocenter Oulu, University of Oulu, 90220 Oulu, Finland.
- Laboratory of Chemistry, Department of Food Science and Human Nutrition, Agricultural University of Athens, 11855 Athens, Greece.
ORCID-Profile: Christiana Mantzourani, Lari Lehtiö, Alexandros E Koumbis
Förderung
- Sigrid Jus?liuksen S??ti?
- Hellenic Foundation for Research and Innovation
- Research Council of Finland
- Jane ja Aatos Erkon S??ti?
Zitieren
APA
Ouzounthanasis, K. A., Bosetti, C., Alaviuhkola, J., Dhakar, S. S., Mantzourani, C., Kokotou, M. G., Kanetidis, D., Lehtiö, L., & Koumbis, A. E. (2025). Discovery of Fused Isoquinolinone/Triazole as a Scaffold for Tankyrase and PARP Inhibition. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c02481
Vancouver
Ouzounthanasis KA, Bosetti C, Alaviuhkola J, Dhakar SS, Mantzourani C, Kokotou MG, et al. Discovery of Fused Isoquinolinone/Triazole as a Scaffold for Tankyrase and PARP Inhibition. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c02481
BibTeX
@article{Ouzounthanasis2025,
author = {Ouzounthanasis, Konstantinos A and Bosetti, Chiara and Alaviuhkola, Juho and Dhakar, Saurabh S and Mantzourani, Christiana and Kokotou, Maroula G and Kanetidis, Demetrios and Lehtiö, Lari and Koumbis, Alexandros E},
title = {Discovery of Fused Isoquinolinone/Triazole as a Scaffold for Tankyrase and PARP Inhibition},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.5c02481}
}
EUVIMED